IDHDP Resources
Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study.
Based on detailed treatment records kept by the Canadian province of British Columbia, a slow taper liberally interspersed with stabilisation periods offers the best chance of sustainably withdrawing from methadone without severe relapse, but still very few manage to avoid this risk – an argument for careful consideration and informed consent before making the attempt.
Based on detailed treatment records kept by the Canadian province of British Columbia, a slow taper liberally interspersed with stabilisation periods offers the best chance of sustainably withdrawing from methadone without severe relapse, but still very few manage to avoid this risk – an argument for careful consideration and informed consent before making the attempt.
Opioid harm in Australia: and comparisons between Australia and Canada
Opioid use and its associated harms is an issue of great public health interest, both within Australia and internationally. This report shows that opioid harms are an issue in both Australia and Canada.
Opioid use and its associated harms is an issue of great public health interest, both within Australia and internationally. This report shows that opioid harms are an issue in both Australia and Canada.
Taking stock: A decade of drug policy - A civil society shadow report
‘Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the world over the past decade, using data from the United Nations (UN), complemented with peer-reviewed academic research and grey literature reports from civil society.
‘Taking stock: A decade of drug policy’ evaluates the impacts of drug policies implemented across the world over the past decade, using data from the United Nations (UN), complemented with peer-reviewed academic research and grey literature reports from civil society.
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial
Unique trial tests what emergency doctors should do when screening identifies opioid dependence. More effective at promoting treatment and curbing opioid use than referral and brief advice was, it seems, actually initiating treatment in the form of buprenorphine maintenance.
Unique trial tests what emergency doctors should do when screening identifies opioid dependence. More effective at promoting treatment and curbing opioid use than referral and brief advice was, it seems, actually initiating treatment in the form of buprenorphine maintenance.
The Role of Research in Driving Progressive Drug Policy Advocacy: Reconsidering Our Approach
Despite statements from our governments that “evidence-based policy” is a priority, “evidence” is often selectively used, or, as is regularly the case with illicit drug policy, ignored all together
Despite statements from our governments that “evidence-based policy” is a priority, “evidence” is often selectively used, or, as is regularly the case with illicit drug policy, ignored all together
NATIONAL MATOD SUMMIT REPORT
Medication Assisted Treatment for Opioid Dependence (MATOD) in Australia
Medication Assisted Treatment for Opioid Dependence (MATOD) in Australia
Public health guidance on prevention and control of blood-borne viruses in prison settings
This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region.
This evidence-based guidance aims to support the planning and implementation of effective programmes to prevent and control the transmission of infectious diseases in prison settings in the European region.
Dr. Robert Newman, Apostle of Methadone Treatment, Dies at 80
Dr. Robert G. Newman at a Manhattan methadone clinic in 2002. He said of heroin addiction, “It’s a medical problem — for which a treatment exists, but for which at the moment a cure does not.”
Dr. Robert G. Newman at a Manhattan methadone clinic in 2002. He said of heroin addiction, “It’s a medical problem — for which a treatment exists, but for which at the moment a cure does not.”
